OrbiMed’s Unicycive Therapeutics UNCY Stock Holding History
Bought
Maintained
Sold
Other funds holding UNCY
DIG
OrbiMed's UNCY Position: Q3 2026 in Review
OrbiMed opened a new position in Unicycive Therapeutics (UNCY) in Q3 2026: 387,000 shares worth $1.82M. The stake represents 0.03% of the portfolio and ranks #117 among its holdings.
90 funds tracked by Wall St. Rank hold UNCY as of Q3 2026.
- OrbiMed held 387,000 shares of Unicycive Therapeutics worth $1.82M as of Q3 2026.
- Unicycive Therapeutics was a new OrbiMed position in Q3 2026.
- Unicycive Therapeutics made up 0.03% of OrbiMed's portfolio in Q3 2026, its #117 holding.
- 90 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q3 2026.
Based on OrbiMed's 13F filing for Q3 2026, filed 16 Nov 2026.